A detailed history of Barclays PLC transactions in Abbott Laboratories stock. As of the latest transaction made, Barclays PLC holds 4,416,984 shares of ABT stock, worth $505 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares
4,416,984
Previous 4,416,984 -0.0%
Holding current value
$505 Million
Previous $504 Million -0.0%
% of portfolio
0.13%
Previous 0.13%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

SELL
$100.07 - $118.13 $327 Million - $386 Million
-3,264,479 Reduced 42.5%
4,416,984 $504 Million
Q2 2024

Aug 14, 2024

BUY
$100.73 - $112.44 $474 Million - $529 Million
4,700,708 Added 157.7%
7,681,463 $798 Million
Q1 2024

May 15, 2024

BUY
$109.52 - $120.96 $22.1 Million - $24.4 Million
201,630 Added 7.26%
2,980,755 $339 Million
Q4 2023

Feb 15, 2024

SELL
$90.19 - $110.4 $45.8 Million - $56.1 Million
-507,887 Reduced 15.45%
2,779,125 $306 Million
Q3 2023

Nov 07, 2023

BUY
$95.53 - $114.62 $7.84 Million - $9.41 Million
82,098 Added 2.56%
3,287,012 $318 Million
Q2 2023

Aug 03, 2023

BUY
$100.78 - $112.29 $191 Million - $213 Million
1,898,517 Added 145.32%
3,204,914 $349 Million
Q1 2023

May 04, 2023

SELL
$96.86 - $114.01 $123 Million - $144 Million
-1,266,971 Reduced 49.23%
1,306,397 $132 Million
Q4 2022

Feb 13, 2023

BUY
$95.06 - $111.52 $45.1 Million - $53 Million
474,944 Added 22.63%
2,573,368 $283 Million
Q3 2022

Nov 03, 2022

BUY
$96.76 - $112.03 $31.7 Million - $36.7 Million
327,513 Added 18.49%
2,098,424 $203 Million
Q2 2022

Aug 12, 2022

SELL
$102.07 - $123.37 $80.4 Million - $97.2 Million
-787,765 Reduced 30.79%
1,770,911 $192 Million
Q1 2022

May 16, 2022

SELL
$114.02 - $139.04 $159 Million - $194 Million
-1,397,299 Reduced 35.32%
2,558,676 $303 Million
Q4 2021

Feb 14, 2022

BUY
$115.53 - $141.46 $84.9 Million - $104 Million
735,104 Added 22.82%
3,955,975 $557 Million
Q3 2021

Nov 09, 2021

BUY
$116.66 - $129.06 $74 Million - $81.9 Million
634,747 Added 24.54%
3,220,871 $380 Million
Q2 2021

Aug 13, 2021

BUY
$105.79 - $124.53 $74.7 Million - $87.9 Million
706,110 Added 37.56%
2,586,124 $300 Million
Q1 2021

May 13, 2021

SELL
$108.84 - $128.23 $16 Million - $18.9 Million
-147,068 Reduced 7.26%
1,880,014 $225 Million
Q4 2020

Feb 11, 2021

SELL
$105.0 - $114.42 $69.6 Million - $75.8 Million
-662,683 Reduced 24.64%
2,027,082 $222 Million
Q3 2020

Nov 12, 2020

BUY
$91.64 - $111.29 $108 Million - $131 Million
1,181,403 Added 78.32%
2,689,765 $293 Million
Q2 2020

Aug 12, 2020

BUY
$76.57 - $98.0 $31.7 Million - $40.5 Million
413,605 Added 37.78%
1,508,362 $138 Million
Q1 2020

May 13, 2020

SELL
$62.82 - $91.86 $122 Million - $178 Million
-1,937,034 Reduced 63.89%
1,094,757 $86.4 Million
Q4 2019

Feb 10, 2020

BUY
$78.51 - $87.4 $59.4 Million - $66.1 Million
756,272 Added 33.24%
3,031,791 $263 Million
Q3 2019

Nov 14, 2019

SELL
$81.84 - $88.74 $37.3 Million - $40.5 Million
-456,121 Reduced 16.7%
2,275,519 $190 Million
Q2 2019

Aug 14, 2019

BUY
$72.88 - $85.0 $31 Million - $36.2 Million
425,400 Added 18.45%
2,731,640 $230 Million
Q1 2019

May 15, 2019

BUY
$66.22 - $80.06 $10.2 Million - $12.4 Million
154,745 Added 7.19%
2,306,240 $184 Million
Q4 2018

Feb 14, 2019

SELL
$65.56 - $74.27 $44.8 Million - $50.8 Million
-684,102 Reduced 24.13%
2,151,495 $156 Million
Q3 2018

Nov 14, 2018

BUY
$60.81 - $73.36 $49.2 Million - $59.4 Million
809,519 Added 39.95%
2,835,597 $208 Million
Q2 2018

Aug 14, 2018

SELL
$57.57 - $63.54 $60.7 Million - $67 Million
-1,054,636 Reduced 34.23%
2,026,078 $124 Million
Q1 2018

May 15, 2018

BUY
$56.27 - $63.62 $54.3 Million - $61.4 Million
964,434 Added 45.57%
3,080,714 $185 Million
Q4 2017

Feb 14, 2018

BUY
$53.68 - $57.47 $64.1 Million - $68.6 Million
1,194,493 Added 129.58%
2,116,280 $121 Million
Q3 2017

Nov 14, 2017

BUY
$48.06 - $53.64 $44.3 Million - $49.4 Million
921,787
921,787 $49.2 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $200B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.